Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

国泰海通证券股份有限公司 关于环旭电子股份有限公司 提前赎回"环旭转债"的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 环旭电子股份有限公司（以下简称"环旭电子"或"公司"） 公开发行可转换公 司债券的保荐人，根据《证券发行上市保荐业务管理办法》《上海证券交易所股 票上市规则》《可转换公司债券管理办法》《上海证券交易所上市公司自律监管指 引第1号——规范运作》等有关规定，对公司提前赎回"环旭转债"的事项进行 了核查，具体情况如下： 一、可转换公司债券基本情况 （一）可转债发行情况 经中国证券监督管理委员会《关于核准环旭电子股份有限公司公开发行可转 换公司债券的批复》（证监许可[2021]167号）核准，公司向社会公开发行 34,500,000张（3,450,000手）可转债，每张面值为人民币100元，共募集资金人民 币3,450,000,000元，扣除各项发行费用人民币19,273,584.91元及对应增值税人民 币1,156,415.09元后的募集资金净额为人民币3,429,570,000.00元。上述募集资金 已全部到位，经德勤华永会计师事务所（特殊普通合伙）审验，并出具了 ...

人民财讯1月8日电，环旭电子（601231）1月8日公告，公司2025年12月合并营业收入为47.67亿元，较 去年同期的合并营业收入减少7.79%，较2025年11月合并营业收入环比减少8.29%。公司2025年1月至12 月合并营业收入为591.95亿元，较去年同期的合并营业收入减少2.46%。 ...

环旭电子（601231）(601231.SH)披露2025年12月营业收入，公司2025年12月合并营业收入为47.67亿 元，较去年同期的合并营业收入减少7.79%，较2025年11月合并营业收入环比减少8.29%。 ...

智通财经APP讯，环旭电子(601231.SH)披露2025年12月营业收入，公司2025年12月合并营业收入为 47.67亿元，较去年同期的合并营业收入减少7.79%，较2025年11月合并营业收入环比减少8.29%。 ...

| 证券代码：601231 | 证券简称：环旭电子 公告编号：2026-004 | | --- | --- | | 转债代码：113045 | 转债简称：环旭转债 | 环旭电子股份有限公司 2025 年 12 月营业收入简报 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 特别提示：本简报所载财务数据为初步核算数据，未经会计师事务所审计， 最终数据以公司定期报告为准，请投资者注意投资风险。 环旭电子股份有限公司（以下简称"公司"）2025 年 12 月合并营业收入为人 民币 4,766,677,706.23 元，较去年同期的合并营业收入减少 7.79%，较 2025 年 11 月合并营业收入环比减少 8.29%。 公司 2025 年 1 月至 12 月合并营业收入为人民币 59,195,055,821.59 元，较去 年同期的合并营业收入减少 2.46%。 公司 2025 年第四季度（2025 年 10 月至 12 月）合并营业收入为人民币 15,553,880,279.79 元，较去年同期的合并营业收入减少 6.77%，较第 ...

格隆汇1月8日｜环旭电子公告，2025年12月合并营业收入为人民币4,766,677,706.23元，较去年同期的合 并营业收入减少7.79%，较2025年11月合并营业收入环比减少8.29%。公司2025年1月至12月合并营业收 入为人民币59,195,055,821.59元，较去年同期的合并营业收入减少2.46%。 ...

公司2025年1月至12月合并营业收入为人民币59,195,055,821.59元，较去年同期的合并营业收入减少 2.46%。 公司2025年第四季度(2025年10月至12月)合并营业收入为人民币15,553,880,279.79元，较去年同期的合 并营业收入减少6.77%，较第三季度(2025年7月至9月)合并营业收入环比减少5.32%。 格隆汇1月8日丨环旭电子(601231.SH)公布，公司2025年12月合并营业收入为人民币47.67亿元，较去年 同期的合并营业收入减少7.79%，较2025 年11月合并营业收入环比减少8.29%。 ...

Core Viewpoint - The company reported a decline in consolidated revenue for December 2025 and the entire year, indicating a downward trend in financial performance compared to the previous year [1]. Group 1: Revenue Performance - The consolidated revenue for December 2025 was RMB 4.767 billion, a decrease of 7.79% compared to the same month last year [1]. - The consolidated revenue for the entire year of 2025 amounted to RMB 59.195 billion, reflecting a decrease of 2.46% year-on-year [1]. - The consolidated revenue for the fourth quarter of 2025 (October to December) was RMB 15.554 billion, down 6.77% from the same quarter last year and down 5.32% from the third quarter of 2025 [1].

Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies, with significant growth percentages noted for众鑫股份, 瑞迈特, and 环旭电子 [1][2] - The companies with the highest target price increases are众鑫股份 (28.45%), 瑞迈特 (20.80%), and 环旭电子 (11.07%), which belong to the packaging printing, medical devices, and consumer electronics industries respectively [1][2] - On January 7, a total of 16 listed companies received broker recommendations, with众鑫股份 receiving recommendations from 2 brokers, while联美控股 and金财互联 received recommendations from 1 broker each [2][4] Group 2 - On January 7, two companies received their first coverage ratings: 联美控股 was rated "增持" (Buy) by 国投证券, and 前沿生物 was rated "推荐" (Recommended) by 国联民生证券 [4][5] - The closing price for众鑫股份 was reported at 77.60 yuan, and it is categorized under the packaging printing industry [4] - The first coverage ratings indicate a positive outlook for both newly covered companies, suggesting potential investment opportunities in the electric power and chemical pharmaceutical sectors [5]